Current healthcare systems are built around the traditional paradigm of patients suffering from a single acute illness, and the field of urology is not exceptional in this respect. As the population ages and becomes more sedentary, however, an increasing number of patients will suffer from underlying conditions such as frailty and/or sarcopenia, which can complicate the treatment of more acute disease such as cancer. It is therefore imperative that healthcare providers expand their awareness of how to care for these patients, as well as how to prevent these conditions in the first place.
The goal of this Next Generation Learning Center is to expand awareness of how conditions such as sarcopenia and obesity interact with urological diseases like prostate cancer. Presentations will focus on management of patients with these increasingly common comorbidities and will also emphasize how diet and exercise can be used to help prevent and mitigate the effects of urologic disease.
Wesley Smith, PhD
University of Miami
Wesley Smith, PhD, joined the faculty at the University of Miami in 2007, and is currently Chair of the Undergraduate Exercise Physiology Program and Director of the Graduate Program in Nutrition and Human Performance, as well as the Chief of Product Development for StrongPath. In 1997, he graduated from Salisbury University with a BS in Exercise Physiology. Dr. Smith then attended the University of Florida, where he earned an MS in Exercise Physiology and began work on his PhD. Dr. Smith transferred to the University of Miami, where he dedicated his research time toward the betterment of muscle testing in the elderly and exploration of new exercise strategies specifically designed to combat age-associated functional decline. To this end, he developed an inexpensive, easy-to-use field test which can quantify lower body muscle power in seniors. Dr. Smith used the research as his dissertation and completed his doctoral degree at the University of Miami. After being hired as a Clinical Assistant Professor, he concentrated on converting the exercise physiology program to a more applied academical model and fostered a growing graduate program in nutrition. He has worked to enhance these academic programs by wielding an applied form of research called Guardrails.
Mark A. Moyad, MD, MPH
University of Michigan Health System
Ann Arbor, Michigan
Fred H. Bartlit, Jr., JD
Bartlit Beck, LLP
Dr. Moyad is the Jenkins/Pokempner Director of Preventive/Complementary and Alternative Medicine (CAM) at the University of Michigan Medical Center in the Department of Urology. He occupies an endowed position, which was originally created and funded entirely by the patients he has helped over the past 25+ years. This was the first endowment of its kind created for a physician at a major medical center in the US. Dr. Moyad has always considered himself to be, first and foremost, a physician public health educator. Dr. Moyad believes in the power of lifestyle changes to improve overall mental, physical, and spiritual wellness, and in their potential ability to keep pill counts and dosages to a minimum, while also enhancing the impact of conventional treatments when needed. This has been the focus of his research and lectures his entire career. Dr. Moyad received his medical education from the University of South Florida College of Public Health and the Wayne State University School of Medicine.
Mr. Bartlit is the founder of Bartlit Beck (Chicago and Denver), a firm described by the National Law Journal as “the nation’s hottest defense boutique, with a roster of litigation stars” as well as a co-founder of StrongPath. The National Law Journal also described Mr. Bartlit as “personally one of the most successful corporate litigators ever, with a long history of big wins.” He has tried cases in 24 different states, the Virgin Islands, and Scotland. He represented President George W. Bush in the election contest filed by former Vice President Al Gore in Tallahassee, Florida, contesting the results of the 2000 Presidential election in Florida. Mr. Bartlit recently completed a successful defense of the ciprofloxacin patent (Cipro), the world’s leading broad-spectrum antibiotic and well-known anti-anthrax drug. For the past decade, he has developed increasingly novel and powerful computerized trial demonstratives, which have been used in numerous trials of issues ranging from patent to antitrust to securities litigation.